Clinical trial
Safety Study of CDP7657 in Patients With Systemic Lupus Erythematosus
To evaluate safety, tolerability pharmacokinetics and immunogenicity of CDP7657.
| Category | Value |
|---|---|
| Study start date | 2013-01-02 |